Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading.

PURPOSE Afterloading high-dose-rate brachytherapy (HDR) treatment of cervical cancer with cross-sectional imaging and three-dimensional (3D) reconstruction offers opportunities for individualized conformal treatment planning rather than fixed point-A dosimetry. METHODS AND MATERIALS Between June 2003 and September 2004, 15 patients with FIGO Stage 1B-4A cervical carcinoma, median age 56 years, were treated with radical external-beam radiotherapy to pelvis, including paraortic nodes if positive on staging investigations. Fourteen patients received concurrent cisplatin chemotherapy. All patients received HDR brachytherapy administered by intrauterine tube and ring applicator. Clinical target volume (CTV) and organs at risk (OAR)--rectum, bladder, and small bowel--were outlined from postinsertion CT planning scans. Planning target volume (PTV) was derived by use of 2-mm to 3-mm 3D expansion. A standard plan was produced that delivered 6 Gy to point A, and a second plan delivered 6 Gy to PTV. Constraints were defined for the OAR: bladder, 6 Gy; rectum, 5 Gy; and small bowel, 5 Gy. Dosimetric comparison was performed by use of the Baltas conformal index (COIN). RESULTS Mean COIN values were 0.39 for conformal plans and 0.33 for standard plans (p = 0.001); mean D95 values were 4.79 Gy and 4.50 Gy, respectively. CONCLUSION The majority of patients achieved a plan closer to ideal for coverage of PTV, with minimization of radiation received by normal tissues for conformal loading measured by COIN compared with fixed point-A prescription that used the cervical ring applicator.

[1]  C. Catton,et al.  Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and urethrography. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Silvia D. Chang,et al.  Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. , 2004, International journal of radiation oncology, biology, physics.

[3]  B. Erickson,et al.  The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix , 2000 .

[4]  D. Rajasekar,et al.  Problems and uncertainties with multiple point A's during multiple high-dose-rate intracavitary brachytherapy in carcinoma of the cervix. , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

[5]  Sasa Mutic,et al.  PET-guided three-dimensional treatment planning of intracavitary gynecologic implants. , 2002, International journal of radiation oncology, biology, physics.

[6]  A Wambersie,et al.  Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  J. Sarkaria,et al.  High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience. , 1999, International journal of radiation oncology, biology, physics.

[8]  D. Baltas,et al.  A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. , 1998, International journal of radiation oncology, biology, physics.

[9]  T. Nakano,et al.  Long‐term results of high‐dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix , 2005, Cancer.

[10]  V. Gebski,et al.  Radiation therapy for cervix carcinoma: benefits of individualized dosimetry. , 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

[11]  J. Masselot,et al.  MR imaging during intracavitary brachytherapy of vaginal and cervical cancer: preliminary results. , 1996, Radiographics : a review publication of the Radiological Society of North America, Inc.

[12]  A. Markoe,et al.  Optimization of high dose-rate cervix brachytherapy; Part I: Dose distribution. , 1991, International Journal of Radiation Oncology, Biology, Physics.

[13]  R. Lanciano,et al.  Optimizing radiation parameters for cervical cancer. , 2000, Seminars in radiation oncology.

[14]  Arterbery Ve High-dose rate brachytherapy for carcinoma of the cervix , 1993 .

[15]  G. Stuecklschweiger,et al.  Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  R. Pötter,et al.  Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  J. Fowler,et al.  Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer. , 1995, International journal of radiation oncology, biology, physics.

[18]  Richard Pötter,et al.  The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  P. Pareek,et al.  Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose-volume histograms. , 2003, Brachytherapy.

[20]  S L Schoeppel,et al.  Three-dimensional treatment planning of intracavitary gynecologic implants: analysis of ten cases and implications for dose specification. , 1994, International journal of radiation oncology, biology, physics.

[21]  H. Hricak,et al.  Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. , 1996, International journal of radiation oncology, biology, physics.

[22]  R. Pötter,et al.  Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. , 2000, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[23]  E Bellon,et al.  The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[24]  M. Kinay,et al.  Optimization in high dose rate brachytherapy for utero-vaginal applications. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  W. E. Decker,et al.  Comparison of traditional low-dose-rate to optimized and nonoptimized high-dose-rate tandem and ovoid dosimetry. , 2001, International journal of radiation oncology, biology, physics.